Advertisement
Screener

TENAX THERAPEUTICS, INC. (TENX) Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable

TENAX THERAPEUTICS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable

TENAX THERAPEUTICS, INC. (TENX) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 3.13 million shares as of 2025-12-31, per its 10-K filed 2026-03-10.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period

us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2026-03-10

  • 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 3.13M shares.
Period endShare-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
2025-12-313.13M shares
10-K · filed 2026-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Cingulate Inc. (CING)United States$0.073B-2.64
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
XBiotech Inc. (XBIT)United States$0.066B-1.56
OS Therapies Inc (OSTX)United States$0.076B-2.17